3,171
Views
34
CrossRef citations to date
0
Altmetric
Original Articles

Hypertension: adherence to treatment in rural Bangladesh – findings from a population-based study

, , , , &
Article: 25028 | Received 25 May 2014, Accepted 02 Sep 2014, Published online: 20 Oct 2014

References

  • Lawes CM, Vander Hoorn S, Rodgers A. Global burden of blood-pressure-related disease, 2001. Lancet. 2008; 371: 1513–8.
  • Lawes CM, Vander Hoorn S, Law MR, Elliott P, MacMahon S, Rodgers A. Blood pressure and the global burden of disease 2000. Part II: estimates of attributable burden. J Hypertens. 2006; 24: 423–30.
  • Law MR, Morris JK, Wald NJ. Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies. BMJ. 2009; 338: b1665.
  • Burt VL, Whelton P, Roccella EJ, Brown C, Cutler JA, Higgins M, etal. Prevalence of hypertension in the US adult population. Results from the Third National Health and Nutrition Examination Survey, 1988–1991. Hypertension. 1995; 25: 305–13.
  • Jonas JB, Nangia V, Matin A, Joshi PP, Ughade SN. Prevalence, awareness, control, and associations of arterial hypertension in a rural central India population: the Central India Eye and Medical Study. Am J Hypertens. 2010; 23: 347–50.
  • Hypertension study group. Prevalence, awareness, treatment and control of hypertension among the elderly in Bangladesh and India: a multicentre study. Bull World Health Organ. 2001; 79: 490–500.
  • Mittal BV, Singh AK. Hypertension in the developing world: challenges and opportunities. Am J Kidney Dis. 2010; 55: 590–8.
  • Whelton PK, He J, Muntner P. Prevalence, awareness, treatment and control of hypertension in North America, North Africa and Asia. J Hum Hypertens. 2004; 18: 545–51.
  • Scheltens T, Bots ML, Numans ME, Grobbee DE, Hoes AW. Awareness, treatment and control of hypertension: the ‘rule of halves’ in an era of risk-based treatment of hypertension. J Hum Hypertens. 2007; 21: 99–106.
  • Wu Y, Huxley R, Li L, Anna V, Xie G, Yao C, etal. Prevalence, awareness, treatment, and control of hypertension in China: data from the China National Nutrition and Health Survey 2002. Circulation. 2008; 118: 2679–86.
  • Ong KL, Cheung BM, Man YB, Lau CP, Lam KS. Prevalence, awareness, treatment, and control of hypertension among United States adults 1999–2004. Hypertension. 2007; 49: 69–75.
  • Sulbaran T, Silva E, Calmon G, Vegas A. Epidemiologic aspects of arterial hypertension in Maracaibo, Venezuela. J Hum Hypertens. 2000; 14(Suppl 1):S6–9.
  • Waeber B, Burnier M, Brunner HR. How to improve adherence with prescribed treatment in hypertensive patients?. J Cardiovasc Pharmacol. 2000; 35(Suppl 3):S23–6.
  • Herttua K, Tabak AG, Martikainen P, Vahtera J, Kivimaki M. Adherence to antihypertensive therapy prior to the first presentation of stroke in hypertensive adults: population-based study. Eur Heart J. 2013; 34: 2933–9.
  • Mancia G, Fagard R, Narkiewicz K, Redon J, Zanchetti A, Bohm M, etal. 2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J. 2013; 34: 2159–219.
  • Viswanathan M, Golin CE, Jones CD, Ashok M, Blalock SJ, Wines RC, etal. Interventions to improve adherence to self-administered medications for chronic diseases in the United States: a systematic review. Ann Intern Med. 2012; 157: 785–95.
  • Khanam MA, Qiu C, Lindeboom W, Streatfield PK, Kabir ZN, Wahlin A. The metabolic syndrome: prevalence, associated factors, and impact on survival among older persons in rural Bangladesh. PLoS One. 2011; 6: e20259.
  • Razzaque A, Nahar L, Sarder AM, van Ginneken J, Shaikh AMK. Demographic surveillance system-Matlab: 1996 socioeconomic census. 1998; Dhaka, Bangladesh: International Centre for Diarrhoeal Disease Research. Scientific Report No. 83.
  • Lindeboom W, Dass SC, Ashraf A. Health and demographic surveillance report 2009–Abhoynagar and Mirsarai. 2011; Dhaka: International Center for Diarrheal Disease Research.
  • Razzaque A, Streatfield PK. 2001; Matlab DSS: Bangladesh. INDEPTH Monograph. Volume 1 Part C. Available from: http://www.indepth-network.org/dss_site_profiles/matlab.pdf..
  • Parr JD, Lindeboom W, Khanam MA, Perez Koehlmoos TL. Diagnosis of chronic conditions with modifiable lifestyle risk factors in selected urban and rural areas of Bangladesh and sociodemographic variability therein. BMC Health Serv Res. 2011; 11: 309.
  • Parr J, Lindeboom W, Khanam M, Sanders J, Koehlmoos TP. Informal allopathic provider knowledge and practice regarding hypertension in urban and rural Bangladesh. PLoS One. 2012; 7: e48056.
  • Razzaque A, Streatfield PK, Gwatkin DR. Does health intervention improve socioeconomic inequalities of neonatal, infant and child mortality? Evidence from Matlab, Bangladesh. Int J Equity Health. 2007; 6(4):
  • Van Minh H, Soonthornthada K, Ng N, Juvekar S, Razzaque A, Ashraf A, etal. Blood pressure in adult rural INDEPTH population in Asia. Glob Health Action. 2009; 2: 60–7.
  • Saquib N, Saquib J, Ahmed T, Khanam MA, Cullen MR. Cardiovascular diseases and type 2 diabetes in Bangladesh: a systematic review and meta-analysis of studies between 1995 and 2010. BMC Public Health. 2012; 12: 434.
  • Zaman MM, Yoshiike N, Rouf MA, Syeed MH, Khan MR, Haque S, etal. Cardiovascular risk factors: distribution and prevalence in a rural population of Bangladesh. J Cardiovasc Risk. 2001; 8: 103–8.
  • Sayeed MA, Banu A, Haq JA, Khanam PA, Mahtab H, Azad Khan AK. Prevalence of hypertension in Bangladesh: effect of socioeconomic risk factor on difference between rural and urban community. Bangladesh Med Res Counc Bull. 2002; 28: 7–18. [PubMed Abstract].
  • Haynes RB, Montague P, Oliver T, McKibbon KA, Brouwers MC, Kanani R. Interventions for helping patients to follow prescriptions for medications. Cochrane Database Syst Rev. 2000 2 CD000011.
  • Bovet P, Burnier M, Madeleine G, Waeber B, Paccaud F. Monitoring one-year compliance to antihypertension medication in the Seychelles. Bull World Health Organ. 2002; 80: 33–9. [PubMed Abstract] [PubMed CentralFull Text].
  • Graves JW. Management of difficult-to-control hypertension. Mayo Clin Proc. 2000; 75: 278–84.
  • WHO. Adherence to long-term therapies: evidence for action. 2003; Switzerland: WHO.
  • Ruilope LM. Long-term adherence to therapy: the clue to prevent hypertension consequences. Eur Heart J. 2013; 34: 2931–2.
  • Botelho RJ, Skinner H. Motivating change in health behavior. Implications for health promotion and disease prevention. Prim Care. 1995; 22: 565–89. [PubMed Abstract].
  • Marentette MA, Gerth WC, Billings DK, Zarnke KB. Antihypertensive persistence and drug class. Can J Cardiol. 2002; 18: 649–56. [PubMed Abstract].
  • Park JH, Shin Y, Lee SY, Lee SI. Antihypertensive drug medication adherence and its affecting factors in South Korea. Int J Cardiol. 2008; 128: 392–8.
  • Monane M, Bohn RL, Gurwitz JH, Glynn RJ, Levin R, Avorn J. The effects of initial drug choice and comorbidity on antihypertensive therapy compliance: results from a population-based study in the elderly. Am J Hypertens. 1997; 10: 697–704.
  • Hudelson P. Gender differentials in tuberculosis: the role of socio-economic and cultural factors. Tuber Lung Dis. 1996; 77: 391–400.
  • Vawter L, Tong X, Gemilyan M, Yoon PW. Barriers to antihypertensive medication adherence among adults–United States, 2005. J Clin Hypertens (Greenwich). 2008; 10: 922–9.
  • Bone LR, Hill MN, Stallings R, Gelber AC, Barker A, Baylor I, etal. Community health survey in an urban African-American neighborhood: distribution and correlates of elevated blood pressure. Ethn Dis. 2000; 10: 87–95. [PubMed Abstract].
  • Saounatsou M, Patsi O, Fasoi G, Stylianou M, Kavga A, Economou O, etal. The influence of the hypertensive patient's education in compliance with their medication. Public Health Nurs. 2001; 18: 436–42.
  • Davis DA, Thomson MA, Oxman AD, Haynes RB. Changing physician performance. A systematic review of the effect of continuing medical education strategies. JAMA. 1995; 274: 700–5.
  • Davis DA, Thomson MA, Oxman AD, Haynes RB. Evidence for the effectiveness of CME. A review of 50 randomized controlled trials. JAMA. 1992; 268: 1111–7.
  • Mendis S, Fukino K, Cameron A, Laing R, Filipe AJr., Khatib O, etal. The availability and affordability of selected essential medicines for chronic diseases in six low- and middle-income countries. Bull World Health Organ. 2007; 85: 279–88.